According to IMARC Group’s latest report “Acute Myeloid Leukemia Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’ the global acute myeloid leukemia therapeutics market size reached US$ 954.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1947.8 Million by 2027, exhibiting a growth rate (CAGR) of 12.8% during 2022-2027.
Acute myeloid leukemia (AML) is a cancer of bone marrow and blood with excess immature white blood cells. It is characterized by breathlessness, fatigue, discoloration of the skin, high body temperatures, bleeding gums, weight loss, and nosebleeds. AML occurs when a bone marrow cell suddenly develops mutations in its deoxyribonucleic acid (DNA) or genetic material and its primary treatment includes chemotherapy, targeted drug, hormone, and radiation therapies, and stem cell transplant.
Request for a PDF Sample of this Report: https://www.imarcgroup.com/acute-myeloid-leukemia-therapeutics-market/requestsample
Acute Myeloid Leukemia Therapeutics Market Trends:
The increasing geriatric population and extended exposure to hazardous chemicals are some of the primary factors accelerating the market growth. Moreover, the surging prevalence of leukemia and the rising consumer awareness regarding the availability of AML therapeutics are propelling the market growth. Furthermore, key market players are investing heavily in research and development (R&D) activities to introduce improved monoclonal antibodies, immunotoxins, and multidrug-resistant modulators, offering enhanced results and efficacy, which is creating a positive outlook for the market. This is further supported by the rapid approval of novel and innovative drugs and burgeoning government funding across the globe. Besides this, the improving healthcare infrastructure and rapid adoption of combination and targeted therapies are providing a considerable thrust to the market growth. Other factors, such as the rapidly expanding healthcare sector and significant technological advancements, are bolstering the market growth.
Acute Myeloid Leukemia Therapeutics Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the acute myeloid leukemia therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbvie Inc.
- Amgen Inc.
- Bristol-Myers Squibb Company
- Celgene
- Roche Holding AG
- Gilead Sciences Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A
- Takeda Pharmaceutical Company Limited.
Key Market Segmentation:
Breakup by Treatment Type:
- Cytarabine
- Anthracycline Drugs
- Alkylating Agents
- Anti-Metabolites
- Tyrosine Kinase Inhibitors
- Others
Breakup by Drug Type:
- Small Molecule Drugs
- Biopharmaceuticals
Breakup by Route of Administration:
- Oral
- Injectables
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3129&flag=E
Note: We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
